Image of ACE (I/D) polymorphism and response to treatment in coronary artery disease: a comprehensive database and meta-analysis involving study quality evaluation

LITERATURE

ACE (I/D) polymorphism and response to treatment in coronary artery disease: a comprehensive database and meta-analysis involving study quality evaluation


In view of available evidence, genetic testing of ACE I/D polymorphism prior to clinical
decision making is not currently justified. The relation between ACE genetic variation and response
to treatment in CAD remains an unresolved issue. The results of long-term and properly designed
prospective studies hold the promise for pharmacogenetically tailored therapy in CAD.


Availability

REQJ690-04Titan CenterAvailable

Detail Information

Series Title
-
Call Number
-
Publisher : .,
Collation
-
Language
English
ISBN/ISSN
-
Classification
NONE
Content Type
-
Media Type
-
Carrier Type
-
Edition
-
Subject(s)
Specific Detail Info
BMC Medical Genetics 2009, 10:50
Statement of Responsibility

Other version/related

No other version available


File Attachment



Information


RECORD DETAIL


Back To Previous